EUVIMEDEUVIMED entdecken
Crossref

Targeting Labile Iron-Mediated Ferroptosis Provides a Potential Therapeutic Strategy for Rhabdomyolysis-Induced Acute Kidney Injury

Haiying Zhu, Jie Cen, Chenggang Hong, Haiyang Wang, Yuanmei Wen, Qiaojun He, Yongping Yu iD, Ji Cao, Wenteng Chen iD

ACS Chemical Biology · 16.06.2023 · 18 (6) · 1294-1304

DOI: 10.1021/acschembio.2c00914 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Biology, online erschienen am 12.05.2023. Verfasst von Haiying Zhu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang…. Hauptthemen laut MEDLINE: Ferroptosis, Acute Kidney Injury, Rhabdomyolysis. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Basic Public Welfare Research Program of Zhejiang Province, Natural Science Foundation of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisAcute Kidney InjuryRhabdomyolysisHumansMiceAnimalsIronIron Chelating Agents

Substanzen

IronIron Chelating Agents

Autor:innen und Institutionen

  • Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
  • College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
  • The Innovation Institute for Artificial Intelligence in Medicine, Zhejiang University, Hangzhou 310058, China.
  • Engineering Research Center of Innovative Anticancer Drugs, Ministry of Education, Hangzhou 310058, China.
  • Cancer Center, Zhejiang University, Hangzhou 310058, China.

ORCID-Profile: Yongping Yu, Wenteng Chen

Förderung

  • Basic Public Welfare Research Program of Zhejiang Province
  • Natural Science Foundation of Zhejiang Province

Zitieren

APA

Zhu, H., Cen, J., Hong, C., Wang, H., Wen, Y., He, Q., Yu, Y., Cao, J., & Chen, W. (2023). Targeting Labile Iron-Mediated Ferroptosis Provides a Potential Therapeutic Strategy for Rhabdomyolysis-Induced Acute Kidney Injury. ACS Chemical Biology, 18(6), 1294-1304. https://doi.org/10.1021/acschembio.2c00914

Vancouver

Zhu H, Cen J, Hong C, Wang H, Wen Y, He Q, et al. Targeting Labile Iron-Mediated Ferroptosis Provides a Potential Therapeutic Strategy for Rhabdomyolysis-Induced Acute Kidney Injury. ACS Chemical Biology. 2023;18(6):1294-1304. doi:10.1021/acschembio.2c00914

BibTeX
@article{Zhu2023,
  author = {Zhu, Haiying and Cen, Jie and Hong, Chenggang and Wang, Haiyang and Wen, Yuanmei and He, Qiaojun and Yu, Yongping and Cao, Ji and Chen, Wenteng},
  title = {Targeting Labile Iron-Mediated Ferroptosis Provides a Potential Therapeutic Strategy for Rhabdomyolysis-Induced Acute Kidney Injury},
  journal = {ACS Chemical Biology},
  year = {2023},
  volume = {18},
  number = {6},
  pages = {1294--1304},
  doi = {10.1021/acschembio.2c00914}
}
Kostenlos starten →